Private Equity
Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.
Sign up for a 7-day FREE trial today!
Latest News in Private Equity
-
August 18, 2017
Travelers Ordered To Cover Standard's Charney Suit Defense
Travelers Indemnity Co. must cover hedge fund Standard General LP's costs to defend a defamation lawsuit brought by American Apparel's ousted CEO Dov Charney, a New York federal judge ruled Friday, finding that a policy exclusion for employment-related claims doesn't bar coverage.
-
August 18, 2017
Uber's Kalanick Invokes Arbitration In Board Seat Lawsuit
Uber Technologies Inc. founder Travis Kalanick on Friday moved to trump a Benchmark Capital Partners LP Delaware lawsuit seeking to oust him from the company’s board, declaring in a bitterly worded motion and brief that disputes over board voting must go to arbitration.
-
August 18, 2017
US Trustee Slams Payments To Ybrant's Bankruptcy Counsel
The U.S. trustee’s office told a New York bankruptcy court Thursday that counsel for Ybrant Digital, which filed for Chapter 11 after getting hit with a $37 million arbitration award in a dispute with a South Korean technology company, should return fees that were purportedly received from unauthorized Ybrant subsidiaries.
-
August 18, 2017
Judge 'Appalled' At Atty's Letter To Ex-Platinum Employee
The New York federal judge overseeing the criminal case against former Platinum Partners executives threatened to throw the book at one of the defendants' Quinn Emanuel Urquhart & Sullivan LLP attorneys on Friday if she hears more of what she deemed “reprehensible” and potentially intimidating contact with could-be witnesses.
-
August 18, 2017
Stada Investors OK Sweetened €4.12B Bain, Cinven Buyout
Enough of Stada Arzneimittel AG investors have backed Bain Capital’s and Cinven’s sweetened €4.12 billion ($4.8 billion) takeover of the German pharmaceutical company for it to move forward, after an earlier buyout offer from the private equity shops fell flat, according to a Friday statement.
Areas of Coverage
- TRANSACTIONS
- Private equity deals valued at $50MM or more
- Venture capital investments of $25MM or more
- Mergers and acquisitions
- Capital investments, including mezzanine and growth capital deals
- Joint ventures involving private equity firms
- Hostile takeovers and leveraged buyouts
- Distressed investment deals
- AGENCIES
- U.S. Commodity Futures Trading Commission
- Federal Trade Commission
- Financial Industry Regulatory Authority
- Public Company Accounting Oversight Board
- U.S. Department of Justice
- U.S. Department of the Treasury
- U.S. Securities and Exchange Commission
- International competition and securities regulators
- POLICY & REGULATION
- Dodd-Frank Act
- Delaware corporate law
- Antitrust and consumer protection controls
- Private equity industry lobbying
- International banking legislation and regulation
- ENFORCEMENT
- Merger reviews
- Second requests
- Challenges and divestitures
- Litigation
- Antitrust suits
- Shareholder disputes
- Corporate governance fights
- Poison pill challenges
- Hostile takeover disputes
- Privacy and consumer protection suits
- Bankruptcy proceedings involving private equity stakeholders
- PROFILES
- Personnel moves
- Profiles of private equity practices
Readership
- Private equity lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the private equity industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals